Over 200 Companies Enhance Study Management Using Veeva CTMS Technology
In an age where efficiency and collaboration are paramount in clinical research, more than 200 organizations are leveraging Veeva CTMS (Clinical Trial Management System) to enhance their study management processes. Among these are 17 of the top 20 biopharmaceutical companies, showcasing the vast adoption of this leading platform within the industry. As clinical studies become more complex, the demand for effective management solutions is more crucial than ever.
Veeva CTMS provides a centralized hub for managing trial data and documents, significantly improving efficiency across all phases of clinical studies. Bonne Adams, Vice President of Operations at Inhibrx, expressed the benefits of Veeva’s system, stating, 'Veeva CTMS serves as the central hub for our studies, allowing seamless flow of study metrics and documentation across our ecosystem.' With teamwork becoming increasingly essential in the current clinical landscape, the ability to integrate operations on a singular platform translates to substantial time and resource savings.
Biopharma companies and Contract Research Organizations (CROs) can now effectively manage and proactively address challenges within clinical trials. Whether these organizations are conducting studies in-house or outsourcing them to partners, Veeva CTMS equips teams to coordinate and monitor various operational facets with agility and clarity. Given the flexibility and scalability of the system, firms can accelerate study execution while ensuring compliance with stringent global regulations such as ICH E6(R2).
The latest strides in Veeva CTMS include the automation of daily data transfers from CROs to sponsors, improving transparency and accountability across the board. Further innovations involve enhanced monitoring capabilities for tracking issues and streamlining the management of integrated and outsourced studies. This new level of oversight has led to faster issue resolution and has optimized roles within clinical teams.
Henry Galio, Vice President of Veeva CTMS Strategy, emphasized the need for modern management systems to accommodate both integration and outsourcing. 'To provide this flexibility, we deliver new features for Veeva CTMS three times a year, continuously evolving the platform to facilitate better collaboration and quicker execution in the industry.’
With an increasing move toward Veeva CTMS, more organizations are simplifying study operations while maintaining compliance, irrespective of their operational models. The platform is a cornerstone of the Veeva Clinical Platform, known for being the most comprehensive and advanced solution for making clinical studies faster and more efficient.
For those involved in biopharmaceuticals, attendance at the upcoming Veeva RD and Quality Summit on June 4-5, 2025, in Madrid will provide invaluable insights into the new functionalities of Veeva CTMS. This summit will be a gathering ground for professionals aiming to delve into advancements aimed at transforming study management.
In conclusion, Veeva Systems stands at the forefront of clinical research management, advocating for innovative solutions that not only enhance the operational capabilities of biopharma organizations but also contribute significantly to the advancement of clinical research as a whole. For more information about Veeva CTMS, visit their website at veeva.com/eu/CTMS and connect with Veeva on LinkedIn to stay updated on the latest industry trends and tools.
Veeva CTMS provides a centralized hub for managing trial data and documents, significantly improving efficiency across all phases of clinical studies. Bonne Adams, Vice President of Operations at Inhibrx, expressed the benefits of Veeva’s system, stating, 'Veeva CTMS serves as the central hub for our studies, allowing seamless flow of study metrics and documentation across our ecosystem.' With teamwork becoming increasingly essential in the current clinical landscape, the ability to integrate operations on a singular platform translates to substantial time and resource savings.
Biopharma companies and Contract Research Organizations (CROs) can now effectively manage and proactively address challenges within clinical trials. Whether these organizations are conducting studies in-house or outsourcing them to partners, Veeva CTMS equips teams to coordinate and monitor various operational facets with agility and clarity. Given the flexibility and scalability of the system, firms can accelerate study execution while ensuring compliance with stringent global regulations such as ICH E6(R2).
The latest strides in Veeva CTMS include the automation of daily data transfers from CROs to sponsors, improving transparency and accountability across the board. Further innovations involve enhanced monitoring capabilities for tracking issues and streamlining the management of integrated and outsourced studies. This new level of oversight has led to faster issue resolution and has optimized roles within clinical teams.
Henry Galio, Vice President of Veeva CTMS Strategy, emphasized the need for modern management systems to accommodate both integration and outsourcing. 'To provide this flexibility, we deliver new features for Veeva CTMS three times a year, continuously evolving the platform to facilitate better collaboration and quicker execution in the industry.’
With an increasing move toward Veeva CTMS, more organizations are simplifying study operations while maintaining compliance, irrespective of their operational models. The platform is a cornerstone of the Veeva Clinical Platform, known for being the most comprehensive and advanced solution for making clinical studies faster and more efficient.
For those involved in biopharmaceuticals, attendance at the upcoming Veeva RD and Quality Summit on June 4-5, 2025, in Madrid will provide invaluable insights into the new functionalities of Veeva CTMS. This summit will be a gathering ground for professionals aiming to delve into advancements aimed at transforming study management.
In conclusion, Veeva Systems stands at the forefront of clinical research management, advocating for innovative solutions that not only enhance the operational capabilities of biopharma organizations but also contribute significantly to the advancement of clinical research as a whole. For more information about Veeva CTMS, visit their website at veeva.com/eu/CTMS and connect with Veeva on LinkedIn to stay updated on the latest industry trends and tools.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.